CervoMed Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
CervoMed Inc. (CRVO) reported Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $1.90 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2016-03-25
- CervoMed Inc. share-based payment arrangement, option, exercise price range, lower range limit for the quarter ending 2013-03-31 was $0.35.
- CervoMed Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2015 was $1.90, a 0.00% change from fiscal 2014.
- CervoMed Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2014 was $1.90.
- CervoMed Inc. share-based payment arrangement, option, exercise price range, lower range limit for fiscal 2011 was $0.14.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 3 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 6 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 9 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 12 month | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $1.90 10-K · filed 2016-03-25 | ||||
| 2014-12-31 | $1.90 10-K · filed 2016-03-25 | $2.50 10-K · filed 2015-04-03 | |||
| 2013-12-31 | $35.00 10-Q · filed 2014-05-20 | ||||
| 2013-03-31 | $0.35 10-Q/A · filed 2013-05-20 | ||||
| 2012-12-31 | $0.14 10-Q/A · filed 2013-05-20 | ||||
| 2012-09-30 | $0.14 10-Q · filed 2012-11-19 | ||||
| 2012-06-30 | $0.14 10-Q/A · filed 2012-09-07 | ||||
| 2011-12-31 | $0.14 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |